Workflow
Zheng Quan Ri Bao
icon
Search documents
金牛化工:截至2025年9月30日,公司股东数为51662户
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,金牛化工在互动平台回答投资者提问时表示,截至2025年9月30日,公司股东 人数为51662户。 (文章来源:证券日报) ...
光大证券:公司充分发挥光大集团协同优势
Zheng Quan Ri Bao· 2026-02-10 13:37
(文章来源:证券日报) 证券日报网讯 2月10日,光大证券在互动平台回答投资者提问时表示,公司充分发挥光大集团协同优 势,坚持"以客户为中心"的发展理念,建设协同场景,挖掘协同资源,支持业务发展,以协同助力公司 强化服务实体经济和落实国家战略的力度和能力。 ...
赛分科技:聘任朱照锦先生为公司财务总监即财务负责人
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,赛分科技发布公告称,公司董事会同意聘任朱照锦先生为公司财务总监即财务 负责人。 (文章来源:证券日报) ...
云路股份:非晶产品产能利用率持续处于较高水平
Zheng Quan Ri Bao· 2026-02-10 13:37
Group 1 - The core viewpoint of the article highlights that Yunlu Co., Ltd. emphasizes the close relationship between its amorphous product business and the global distribution transformer industry development [2] - The company reports that its amorphous product capacity utilization rate has remained at a high level in recent years [2]
武商集团:当前公司经营保持平稳
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,武商集团在互动平台回答投资者提问时表示,公司暂未收到证监会就相关经营 与市场表现事项的问询或调查通知,当前公司经营保持平稳,财务指标符合上市规则要求,未触及退市 风险警示情形。公司第一大股东持续秉持对股东及市场高度负责的态度,严格遵守法律法规及国资监管 要求,稳步推进公司治理和业务发展,全力维护公司价值和股东权益。公司将持续关注市场动态,不断 提升治理水平和经营质量,努力为股东创造长期价值。 (文章来源:证券日报) ...
均瑶健康:公司采用“自主菌株突破+产学研协同深化+产能同步落地”的三位一体研发策略
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - Junyao Health adopts a three-pronged R&D strategy focusing on "independent strain breakthroughs, collaborative research with academia, and synchronized capacity implementation" to enhance its probiotic product matrix and maintain a competitive edge in technology [2] Group 1: R&D Strategy - The company emphasizes core strain independent research to establish technological barriers, particularly in fermentation technology and strain selection [2] - Junyao Health collaborates with universities and research institutions to build joint laboratories, accelerating the transformation of cutting-edge research results [2] - The company is committed to evidence-based research, aiming to catch up with international leading levels and closely integrating R&D outcomes with large-scale production capacity [2] Group 2: Production and Sales - The company enhances production efficiency through intelligent manufacturing processes, improving technical parameters [2] - Junyao Health has completed multiple outsourced R&D projects and patent applications, contributing to its comprehensive industry chain from R&D to production and sales [2] - The integration of technology innovation supports the enrichment and upgrading of the probiotic product matrix, forming a complete closed-loop industry chain [2]
安凯微:更高制程的芯片在规划中
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - Ankai Micro is planning higher process chips and will provide updates through regular or temporary reports, focusing on the needs of intelligent terminal devices regarding power consumption, integration, and processing performance [2] Group 1 - The company is responding to investor inquiries about the development of higher process chips [2] - The product development will consider the comprehensive needs of edge and endpoint intelligent terminals [2] - Continuous upgrades will be made based on requirements for power consumption, integration, and processing performance [2]
溢多利:公司立足生物产业,致力于生物技术在营养与健康、食品饮料等领域的绿色、安全、高效应用
Zheng Quan Ri Bao· 2026-02-10 13:37
证券日报网讯 2月10日,溢多利在互动平台回答投资者提问时表示,公司立足生物产业,致力于生物技 术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域 的绿色、安全、高效应用。 (文章来源:证券日报) ...
麦格米特:截至2026年1月30日,公司股东人数为52000多户
Zheng Quan Ri Bao· 2026-02-10 13:37
Group 1 - The core point of the article is that as of January 30, 2026, the number of shareholders for the company Magmi Tech is over 52,000 [2]
可孚医疗:公司无逾期对外担保
Zheng Quan Ri Bao· 2026-02-10 13:37
Core Viewpoint - The announcement from Kewei Medical indicates that the total guarantees provided by the company amount to RMB 43,307.47 million, which represents 9.03% of the company's most recent audited net assets attributable to shareholders [2] Group 1 - The total amount of guarantees provided by the company is RMB 43,307.47 million [2] - The guarantees are exclusively for the company's wholly-owned subsidiaries [2] - There are no overdue external guarantees, no litigation related to external guarantees, and no losses incurred from guarantees resulting in adverse judgments [2]